Roger Longman, Founder and Chairman
Roger co-founded Real Endpoints in 2011 to focus on a key 21st century challenge for medical innovation: paying for it. Since its beginning, the company has grown substantially, particularly with the addition of several extraordinary executives from the payer and biopharmaceutical worlds and the creation of several subscription-based tools.
He has been involved with the health-care industry for more than 30 years. At Roger’s first venture, Windhover Information, he and his team created a number of industry-standard analytical sources, including must-read strategy publications such as IN VIVO and Start-Up, the Strategic Transactions database, and a major conference business for senior executives. The business was acquired by Elsevier where for two years Longman ran the company’s pharmaceutical business information group.
Roger is recognized as an expert in biopharmaceutical strategy and reimbursement and often speaks at key industry events organized by important trade organizations, investment banks, venture capital firms, and leading biopharma companies. He also lectures regularly at several leading universities and co-directed the Wharton-Windhover pharmaceutical program at The Wharton School. Mr. Longman completed his BA at Cornell University and MA at the University of North Carolina at Chapel Hill, then taught for three years at the European division of the University of Maryland.